Re appointment of Mr. Murali Meraga (DIN:05237507) as an Managing Director of the company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vista Pharmaceuticals' Board has approved the re-appointment of Mr. Murali Meraga (DIN: 02537507) as Managing Director for a second term of 3 years, effective from 19 October 2025 to 18 October 2028. The decision, taken at the Board meeting on 13 August 2025, was based on the recommendation of the Nomination and Remuneration Committee and is subject to shareholder approval. Mr. Meraga holds a B.Tech degree and brings experience in Marketing, Administration, Finance, and Foreign Exchange management. He currently holds 90,00,000 equity shares in the company, is not related to any Director, KMP, or Promoter, and is not debarred by SEBI or any other authority.
This is a continuity move with no change in leadership direction expected. Shareholders will need to approve the re-appointment at the next general meeting for it to take effect.